Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind Controlled Comparison of NRX-101 to Lurasidone for Adults With Bipolar Depression and Subacute Suicidal Ideation or Behavior

NCT03395392 is registered in ClinicalTrials.gov with NeuroRx, Inc. as lead sponsor.

NCT NCT03395392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind Controlled Comparison of NRX-101 to Lurasidone for Adults With Bipolar Depression and Subacute Suicidal Ideation or Behavior
Lead sponsor
NeuroRx, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
May 12, 2022
Completion date
March 30, 2024
Enrollment
74 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, suicidal ideation and behavior